Lamotrigin Stada (Lamotrigine)

Lamotrigine works by inhibiting voltage‑gated sodium channels on neuronal membranes, which reduces the rapid influx of sodium during depolarization. This stabilizes neuronal firing and lowers the release of excitatory neurotransmitters such as glutamate, helping to prevent seizure propagation and to modulate mood‑related pathways.

The appropriate dose of Lamotrigin Stada is individualized and set by the prescribing clinician. Factors influencing the regimen include the specific indication, patient age, renal and hepatic function, concomitant medications, and response to therapy. Patients should follow the prescriber’s instructions without self‑adjusting the dose.

Safety data for lamotrigine in pregnancy and lactation are limited. The drug is classified as having an unknown pregnancy category, and potential risks to the fetus must be weighed against therapeutic benefits. Breastfeeding mothers should discuss possible exposure with a healthcare professional before continuing therapy.

To request Lamotrigin Stada, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will ask for trade or institutional credentials. The team then replies with pricing, availability, shipping details and any necessary import documentation.

Both lamotrigine and carbamazepine are anticonvulsants, but they differ in mechanisms and safety profiles. Lamotrigine primarily blocks sodium channels and has a lower risk of drug‑induced hyponatremia, while carbamazepine also induces hepatic enzymes, leading to more drug‑drug interactions. Lamotrigine is often preferred for mood stabilization in bipolar disorder.

Lamotrigin Stada should be stored at room temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability throughout its shelf life.

Lamotrigin Stada is taken orally as a tablet. Patients should swallow the tablet whole with water, and it may be taken with or without food. The dosing schedule, including any titration, is determined by the prescriber based on the individual’s clinical condition.

The most serious risks include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, as well as hematologic abnormalities like agranulocytosis or aplastic anemia. Prompt medical attention is required if a rash or signs of blood dyscrasia develop, and the drug should be discontinued immediately.

Lamotrigine should be avoided in individuals with a known hypersensitivity to the drug or any of its components. Patients with severe hepatic impairment, or those taking contraindicated enzyme‑inducing antiepileptics without appropriate dose adjustment, should not use it without specialist guidance.